Researcher profile

Alexandros-Stavros Iliopoulos

Alexandros-Stavros Iliopoulos contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
7topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Accelerating Training and Inference of Graph Neural Networks with Fast Sampling and Pipelining

Improving the training and inference performance of graph neural networks (GNNs) is faced with a challenge uncommon in general neural networks: creating mini-batches requires a lot of computation and data movement due to the exponential growth of multi-hop graph neighborhoods along network layers. Such a unique challenge gives rise to a diverse set of system design choices. We argue in favor of performing mini-batch training with neighborhood sampling in a distributed multi-GPU environment, under which we identify major performance bottlenecks hitherto under-explored by developers: mini-batch preparation and transfer. We present a sequence of improvements to mitigate these bottlenecks, including a performance-engineered neighborhood sampler, a shared-memory parallelization strategy, and the pipelining of batch transfer with GPU computation. We also conduct an empirical analysis that supports the use of sampling for inference, showing that test accuracies are not materially compromised. Such an observation unifies training and inference, simplifying model implementation. We report comprehensive experimental results with several benchmark data sets and GNN architectures, including a demonstration that, for the ogbn-papers100M data set, our system SALIENT achieves a speedup of 3x over a standard PyTorch-Geometric implementation with a single GPU and a further 8x parallel speedup with 16 GPUs. Therein, training a 3-layer GraphSAGE model with sampling fanout (15, 10, 5) takes 2.0 seconds per epoch and inference with fanout (20, 20, 20) takes 2.4 seconds, attaining test accuracy 64.58%.

preprint2021arXiv

Challenges in biomarker discovery and biorepository for Gulf-war-disease studies: a novel data platform solution

Aims: Our Gulf War Illness (GWI) study conducts combinatorial screening of many interactive neural and humoral biomarkers in order to establish predictive, diagnostic, and therapeutic targets. We encounter obstacles at every stage of the biomarker discovery process, from sample acquisition, bio-marker extraction to multi-aspect, multi-way interaction analysis, due to the study complexity and lack of support for complex data problem solutions. We introduce a novel data platform, named ROSALIND, to overcome the challenges, foster healthy and vital collaborations and advance scientific inquiries. Main methods: ROSALIND is a researcher-centered, study-specific data platform. It provides vital support of individual creativity and effort in collaborative research. We follow the principles etched in the platform name - ROSALIND stands for resource organisms with self-governed accessibility, linkability, integrability, neutrality, and dependability. We translate, encode and implement the principles in the platform with novel use of advanced concepts and techniques to ensure and protect data integrity and research integrity. From a researcher's vantage point, ROSALIND embodies nuance utilities and advanced functionalities in one system, beyond conventional storage, archive and data management. Key findings: The deployment of ROSALIND in our GWI study in recent 12 months has accelerated the pace of data experiment and analysis, removed numerous error sources, and increased research quality and productivity. Significance: ROSALIND seems the first to address data integrity and research integrity in tandem with digital measures and means. It also promises a new type of distributed research networks with individualized data platforms connected in various self-organized collaboration configurations.

preprint2020arXiv

iPhantom: a framework for automated creation of individualized computational phantoms and its application to CT organ dosimetry

Objective: This study aims to develop and validate a novel framework, iPhantom, for automated creation of patient-specific phantoms or digital-twins (DT) using patient medical images. The framework is applied to assess radiation dose to radiosensitive organs in CT imaging of individual patients. Method: From patient CT images, iPhantom segments selected anchor organs (e.g. liver, bones, pancreas) using a learning-based model developed for multi-organ CT segmentation. Organs challenging to segment (e.g. intestines) are incorporated from a matched phantom template, using a diffeomorphic registration model developed for multi-organ phantom-voxels. The resulting full-patient phantoms are used to assess organ doses during routine CT exams. Result: iPhantom was validated on both the XCAT (n=50) and an independent clinical (n=10) dataset with similar accuracy. iPhantom precisely predicted all organ locations with good accuracy of Dice Similarity Coefficients (DSC) >0.6 for anchor organs and DSC of 0.3-0.9 for all other organs. iPhantom showed less than 10% dose errors for the majority of organs, which was notably superior to the state-of-the-art baseline method (20-35% dose errors). Conclusion: iPhantom enables automated and accurate creation of patient-specific phantoms and, for the first time, provides sufficient and automated patient-specific dose estimates for CT dosimetry. Significance: The new framework brings the creation and application of CHPs to the level of individual CHPs through automation, achieving a wider and precise organ localization, paving the way for clinical monitoring, and personalized optimization, and large-scale research.